Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Prof Nawangwe said Makerere University — ranked second in Africa and 63rd globally — continues to bolster its profile as a ...

The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

African kingdom has accepted 15 men as part of a third-country deportation program. This program, which has been strongly ...